Levothyroxine sodium and Coronary artery disease aggravated - a phase IV clinical study of FDA data

Summary:

Coronary artery disease aggravated is found among people who take Levothyroxine sodium, especially for people who are female, 60+ old, have been taking the drug for 10+ years.

The phase IV clinical study analyzes which people take Levothyroxine sodium and have Coronary artery disease aggravated. It is created by eHealthMe based on reports of 104,786 people who have side effects when taking Levothyroxine sodium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 03, 2023

104,786 people reported to have side effects when taking Levothyroxine sodium.
Among them, 398 people (0.38%) have Coronary artery disease aggravated.


What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 111,500 Levothyroxine sodium users for its effectiveness, alternative drugs and more.

What is Coronary artery disease aggravated?

Coronary artery disease aggravated (worse plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart) is found to be associated with 1,212 drugs and 416 conditions by eHealthMe.

Number of Levothyroxine sodium and Coronary artery disease aggravated reports submitted per year:

Could Levothyroxine sodium cause Coronary artery disease aggravated?

Time on Levothyroxine sodium when people have Coronary artery disease aggravated *:

Click here to view

Gender of people who have Coronary artery disease aggravated when taking Levothyroxine sodium*:

Click here to view

Age of people who have Coronary artery disease aggravated when taking Levothyroxine sodium *:

Click here to view

Common drugs people take besides Levothyroxine sodium *:

Click here to view

Common side effects people have besides Coronary artery disease aggravated *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Levothyroxine sodium and have Coronary artery disease aggravated?

Check whether Coronary artery disease aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Coronary artery disease aggravated and when was it recovered:

Expand to all the drugs that have ingredients of levothyroxine sodium:

Alternative drugs to, pros and cons of Levothyroxine sodium:

Common Levothyroxine sodium side effects:

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Coronary artery disease aggravated treatments and more:

COVID vaccines that are related to Coronary artery disease aggravated:

Common drugs associated with Coronary artery disease aggravated:

All the drugs that are associated with Coronary artery disease aggravated:

Common conditions associated with Coronary artery disease aggravated:

All the conditions that are associated with Coronary artery disease aggravated:

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Levothyroxine sodium) and Levothyroxine sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: